A-Rod denies PED use report; MLB investigates
Alex Rodriguez was again ensnared in a doping investigation Tuesday when an alternative weekly newspaper reported baseball's highest-paid player was among six players listed in records of a Florida clinic the paper said sold performance-enhancing drugs.
The Miami New Times said the three-time American League MVP bought human growth hormone and other performance-enhancing substances during 2009-12 from Biogenesis of America LLC, a now-closed anti-aging clinic in Coral Cables, Fla.
The public relations firm for the Yankees third baseman issued a statement denying the allegations.ESPN reported that the Yankees are exploring avenues to void Rodriguez's contract, which has five years and $114 million remaining.
The New Times said it obtained records detailing purchases by Rodriguez, 2012 All-Star Game MVP Melky Cabrera, 2005 AL Cy Young Award winner Bartolo Colon and 2011 AL Championship Series MVP Nelson Cruz of Texas.
Cabrera signed with Toronto in the offseason, while Oakland re-signed Colon. Other baseball players the newspaper said appeared in the records include Washington pitcher Gio Gonzalez and San Diego catcher Yasmani Grandal.
Biogenesis, which the New Times said was run by Anthony Bosch, was located in a nondescript office park. The clinic is no longer listed as a business in its directory.
“There was a flier put out by the building management a couple weeks ago. It was put on all the doors and windows of all the offices,” said Brad Nickel, who works in a group cruise planning company on the floor above where the clinic was located. “It just said this guy's not really a doctor, he doesn't belong here, he's no longer allowed here, call the police or the building management if you see him.”
The New Times posted copies of what it said were Bosch's handwritten records, obtained through a former Biogenesis employee.
Rodriguez appears 16 times in the documents it received, the paper said, either as “Alex Rodriguez,” “Alex Rod” or the nickname “Cacique,” a pre-Columbian Caribbean chief.
Rodriguez admitted four years ago that he used PEDs from 2001-03. Cabrera, Colon and Grandal were suspended for 50 games last year by MLB following tests for elevated testosterone. Responding to the testosterone use, MLB and the players' union said Jan. 10 they were authorizing the World Anti-Doping Agency laboratory outside Montreal to store each major leaguer's baseline testosterone/epitestosterone (T/E) ratio to detect abnormalities.
“We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances,” MLB said in a statement. “We are in the midst of an active investigation and are gathering and reviewing information.”
A baseball official, speaking on condition of anonymity because he was not authorized to make public statements, said MLB did not have any documentation regarding the allegations. If MLB does obtain evidence, the players could be subject to discipline. First offenses result in a 50-game suspension and second infractions in 100-game penalties. A third violation results in a lifetime ban.
Rodriguez is sidelined for at least the first half of the season after hip surgery Jan. 16.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.